
Company Info
Year Established2018
Contacts
Michael G. Fehlings MD, PhD, FRCSC, FACSFounder & President
Company Description
Inteligex is developing innovative stem cell and drug-based therapies for traumatic spinal cord injury.

Inteligex is developing innovative stem cell and drug-based therapies for traumatic spinal cord injury.